Immunological and Genetic Markers of Rheumatoid Arthritis Among Women in North India: A Case-Control Study

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2025 | Volume : 3 | 02 | Page :
    By

    Atul khajuria,

  • Eric Kwasi Elliason,

  • J. Samuel Kamanda1,

  • Stephen Monday,

  1. DIRECTOR, Faculty of Allied Health Sciences, Desh Bhagat University, Mandi Gobindgarh, Punjab, India
  2. Research fellow, Faculty of Allied Health Sciences, Desh Bhagat University, Mandi Gobindgarh, Punjab, India
  3. Research fellow, Faculty of Allied Health Sciences, Desh Bhagat University, Mandi Gobindgarh, Punjab, India
  4. Research fellow, Faculty of Allied Health Sciences, Desh Bhagat University, Mandi Gobindgarh, Punjab, India

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_203768’);});Edit Abstract & Keyword

Rheumatoid arthritis (RA) is an autoimmune disease systemically afflicting women marked by chronic inflammation around the involved joints leading to joints destruction. It has both endocrinological and immunological associations as well as genetic associations but data pertaining to women of North India is scanty. Objective: This case-control study was done to evaluate the presence and significance of major immunological and genetic markers of RA in North Indian women with the disease and comparing them with healthy controls to establish potential links of immunological markers and genetic markers with disease susceptibility. Methods: A total of 790 participants were enrolled (570 RA cases, 220 controls). Immunological markers RF, ACPA, ESR and CRP were quantified. Genetic polymorphisms of HLA-DRB1, PTPN22, STAT4, TRAF1/C5 and IL23R were analyzed using PCR based methods. Significant differences were calculated using logistic regression and chi-square tests. Results: The prevalence of RF was 73.7%, ACPAs were 66.7%, ESR elevation was 59.6%, and CRP was 54.4% compared to controls indicating significant differences. Moreover, cases were also noted to harbor risk alleles of HLA-DRB1 (56.1), PTPN22 (36.8), STAT4 (31.6), TRAF1/C5 (26.3), and IL23R (15.8) confirming their association with RA at significantly higher odds of 1.9 to 5.1. Of the antibodies studied, greatest association was noted with ACPAs (OR = 5.1, p < 0.001) followed by RF then HLA-DRB1. Conclusion: The results of the study suggest that the clinical and genetic markers of immunity are strongly related to the susceptibility of rheumatoid arthritis in women living in the northern part of India. Implementation of serological testing along with genetic profiling could improve the management of RA in this population through early diagnosis and tailored treatment plans.

Keywords: Rheumatoid arthritis, ACPAs, HLA-DRB1, immunological markers, genetic polymorphism, autoimmune disease, inflammation, North Indian women

How to cite this article:
Atul khajuria, Eric Kwasi Elliason, J. Samuel Kamanda1, Stephen Monday. Immunological and Genetic Markers of Rheumatoid Arthritis Among Women in North India: A Case-Control Study. International Journal of Genetic Modifications and Recombinations. 2025; 03(02):-.
How to cite this URL:
Atul khajuria, Eric Kwasi Elliason, J. Samuel Kamanda1, Stephen Monday. Immunological and Genetic Markers of Rheumatoid Arthritis Among Women in North India: A Case-Control Study. International Journal of Genetic Modifications and Recombinations. 2025; 03(02):-. Available from: https://journals.stmjournals.com/ijgmr/article=2025/view=0


document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_203768’);});Edit

References

  1. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–38.
  2. van Vollenhoven RF. Sex differences in rheumatoid arthritis: More than meets the eye. BMC Med. 2009;7:12.
  3. Aletaha D, Neogi T, Silman AJ, et al. Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580–8.
  4. Raychaudhuri S. Recent advances in the genetics of rheumatoid arthritis. Curr Opin Rheumatol. 2010;22(2):109–18.
  5. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev. 2005;4(3):130–6.
  6. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. Arthritis Rheum. 2000;43(1):155–63.
  7. van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibodies: The past, the present and the future. Nat Rev Rheumatol. 2011;7(7):391–8.
  8. Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: Role of antibodies to citrullinated peptides (anti-CCP). Arthritis Rheum. 2004;50(1):208–15.
  9. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30(11):1205–13.
  10. Hill JA, Southwood S, Sette A, et al. Cutting edge: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the RA-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003;171(2):538–41.
  11. Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Nat Genet. 2004;36(4):337–8.
  12. Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007;357(10):977–86.
  13. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1–C5 as a risk locus for rheumatoid arthritis—a genomewide study. N Engl J Med. 2007;357(12):1199–209.
  14. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314(5804):1461–3.
  15. Eyre S, Bowes J, Diogo D, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet. 2012;44(11):1336–40.
  16. Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH. HLA-DRB1 alleles and rheumatoid arthritis in South Asians. J Rheumatol. 2010;37(5):123–9.
  17. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569–81.
  18. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. Arthritis Rheum. 2006;30(11):1205–13.
  19. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314(5804):1461–3.
  20.  McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205–19.
  21.  Nielen MMJ, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380–6.
  22. Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014;506(7488):376–81.
  23.  Wells G, Anderson J, Boers M, et al. Measurement of joint function and disease activity in rheumatoid arthritis. Ann Rheum Dis. 2003;62(3):212–5.
Ahead of Print Subscription Original Research
Volume 03
02
Received 21/04/2025
Accepted 03/07/2025
Published 25/08/2025
Publication Time 126 Days
21

[last_name]

My IP

PlumX Metrics